GlobeNewswire 01/07/2014 Sobi awarded Company of the Year at the European Mediscience Awards 2014
GlobeNewswire 25/06/2014 Sobi files for EU approval of Xiapex for Peyronies disease
GlobeNewswire 16/06/2014 Sobi to review preclinical data to potentially add future haemophilia A candidate to collaboration a...
GlobeNewswire 09/06/2014 The US Food and Drug Administration (FDA) approves Eloctate(TM)
GlobeNewswire 05/06/2014 Sobi Establishes North American Office in Massachusetts
GlobeNewswire 26/05/2014 Swedish Orphan Biovitrum AB (publ): Sobi appoints Kirsti Gjellan as Senior Vice President Manufactur...
GlobeNewswire 12/05/2014 Biogen Idec and Sobi to donate 1 billion international units of clotting factor to support treatment...
GlobeNewswire 08/05/2014 Swedish Orphan Biovitrum AB (publ): Resolutions from Sobi's AGM
GlobeNewswire 08/05/2014 Swedish Orphan Biovitrum AB (publ): Annette Clancy joins Sobi's Board of Directors
GlobeNewswire 08/05/2014 Sobi publishes Report for the First Quarter 2014
GlobeNewswire 30/04/2014 Invitation - Presentation of Sobi's first quarter results 2014
GlobeNewswire 16/04/2014 Sobi publishes Annual Report 2013
GlobeNewswire 14/04/2014 Auxilium and Sobi announce encore presentation of Xiapex data at European Association of urology con...
GlobeNewswire 10/04/2014 Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric ...
GlobeNewswire 07/04/2014 Sobi becomes market authorisation holder for Xiapex in Europe
GlobeNewswire 03/04/2014 Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
GlobeNewswire 03/04/2014 Sobi enters partnership with Tigenix for the commercialisation of ChondroCelect
GlobeNewswire 01/04/2014 Sobi assumes direct responsibility for Orfadin® (nitisinone) in US and Canada and introduces Orfadin...
GlobeNewswire 31/03/2014 Sobi: US FDA approves Alprolix(TM)
GlobeNewswire 26/03/2014 Sobi: Kiobrina pivotal phase 3 study did not meet primary endpoint
GlobeNewswire 25/03/2014 Cometriq® approved in Europe for the treatment of progressive, unresectable locally advanced or meta...
GlobeNewswire 21/03/2014 Health Canada approves Alprolix(TM)
GlobeNewswire 26/02/2014 Sobi receives EURORDIS Company Award 2014
GlobeNewswire 20/02/2014 Sobi publishes its Report for the Fourth Quarter and Full Year 2013
GlobeNewswire 10/02/2014 Invitation - Presentation of Sobi's fourth quarter and full year results 2013